A. P. Chavan, A. B. Pinjari, and P. C. Mhaske
Vol 000
4-((Benzo[d][1,3]dioxol-5-yl)methylene)-3-(chloromethyl)
isoxazol-5(4H)-one (Table 3, entry 5e). mp 184–186 °C; IR
Ar-H), 7.62–7.65 (m, 1H, Ar-H), 8.14–8.17 (m, 1H, Ar-H), 8.46
(s, 1H, ¼CH), 9.56 (d, J = 3.0 Hz, 1H, indole-H), 13.03 (bs, 1H,
HN–); 13C NMR (75 MHz, DMSO-d6) δ 35.5, 108.3, 112.3,
112.7, 118.4, 122.1, 123.5, 127.5, 135.9, 138.0, 140.0, 161.2,
169.9; HRMS (m/z): 261.0447 (M+ H)+.
(KBr) 1730, 1589, 1530, 1429, 1220, 1102, 878 cmꢀ1; H NMR
(400MHz, DMSO-d6) δ 4.84 (s, 2H, Cl-CH2-isoxazol), 6.22
(s, 2H, O-CH2-O), 7.14 (d, J = 8.2 Hz, 1H, Ar-H), 7.87
(dd, J = 8.32 and 1.72Hz, 1H, Ar-H), 8.02 (s, 1H, ¼CH), 8.40
(d, J = 1.72Hz, 1H, Ar-H); 13C NMR (100 MHz, DMSO-d6) δ
34.9, 102.8, 108.9, 111.4, 112.1, 127.2, 134.3, 148.0, 152.4,
153.5, 161.5, 168.0; HRMS (m/z): 266.0232 (M + H).+
1
Acknowledgments. The authors would like to express sincere
thanks to the University Grant Commission (UGC), New Delhi,
India, for providing the financial assistance. The Department of
Chemistry, University of Pune and SAIF, Panjab University,
Chandigarh, India, are also acknowledged for spectral analysis.
4-(4-Hydroxy-3-methoxybenzylidene)-3-(chloromethyl)isoxazol-
5(4H)-one (Table 3, entry 5f). mp 184–186 °C; IR (KBr) 3350,
1748, 1555, 1451, 1418, 1174, 1079, 930 cmꢀ1 1H NMR
;
(400 MHz, DMSO-d6) δ 3.88 (s, 3H, H3C–O), 4.77 (s, 2H, Cl-
CH2-isoxazol), 6.95 (d, J= 8.8 Hz, 1H, Ar-H), 7.80 (dd, J= 8.8 and
2 Hz, 1H, Ar-H), 7.90 (s, 1H, ¼CH), 8.55 (d, J= 2 Hz, 1H, Ar-H)
10.83 (bs, 1H, Ar-OH); 13C NMR (100 MHz, DMSO-d6) δ 34.9,
55.5, 110.0, 115.8, 116.5, 124.9, 132.5, 147.5, 152.7, 154.7, 161.3,
168.5; HRMS (m/z): 268.0377 (M + H)+.
REFERENCES AND NOTES
[1] Li, C. J. Chem Rev 1993, 93, 2023.
[2] Bigi, F.; Conforti, M. L.; Maggi, R.; Piccinno, A.; Sartori, G.
Green Chem 2000, 2, 101.
[3] Lindstrom, U. M. Chem Rev 2002, 102, 2751.
[4] Otto, S.; Engberts, J. J Org Biomol Chem 2003, 1, 2809.
[5] Narayan, S.; Muldoon, J.; Finn, M. G.; Fokin, V. V.; Kolb, H. C.;
Sharpless, K. B. Angew Chem Int Ed 2005, 44, 3275.
[6] Li, C. J Chem Rev 2005, 105, 3095.
[7] Pirrung, M. C. Chem–Eur J 2006, 12, 1312.
[8] Chanda, A. V.; Fokin, V. Chem Rev 2009, 109, 725.
[9] Butler, R. N.; Coyne, A. G. Chem Rev 2010, 110, 6302.
[10] Simon, M. O.; Li, C. J. Chem Soc Rev 2012, 41, 1415.
[11] Shilaja, M.; Manjula, A.; Vittal Rao, B. Indian J Chem 2011,
50B, 214.
[12] Ishioka, T.; Tanatani, A.; Nagasawa, K.; Hashimoto, Y.
Bioorg Med Chem 2003, 13, 2655.
[13] Deng, B. L.; Hartman, T. L.; Robert, J.; Buckheit, W.;
Pannecouque, C.; Clercq, E. D.; Cushman, M. J Med Chem 2006, 49,
5316.
[14] Laughlin, S. K.; Clark, M. P.; Djung, J. F.; Golebiowski, A.;
Brugel, T. A.; Sabat, M.; Bookland, R. G.; Laufersweiler, M. J.; Van
Rens, R. L.; Townes, J. C.; De, B.; Hsieh, L. C.; Xu, S. C.; Walter, M. J.;
Mekel, M. J.; Janusz, J. A. Bioorg Med Chem Lett 2005, 15, 2399.
[15] Flores, A. F. C.; Zanatta, N.; Rosa, A.; Brondani, S.
Tetrahedron Lett 2002, 43, 5005.
[16] Singh, V.; Saxena, R.; Batra, S. J Org Chem 2005, 70, 353.
[17] Renard, D.; Rezaei, H.; Zard, S. Z. Synlett 2002, 8, 1257.
[18] Alias, R.; Andreu, M. J.; Blesa, M. A.; Cerdan, S.; Franco, J.
J Org Chem 2008, 73, 5890.
[19] Cheng, Q. F.; Liu, X. Y.; Wang, Q. F.; Liu, L. S.; Liu, W. J.;
Lin, Q.; Yang, X. J. Chin J Org Chem 2009, 29, 1267.
[20] Zhang, X. Z.; Zhan, Y. Z.; Chen, D.; Wang, F.; Wang L. Y.
Dyes Pigments 2012, 93, 1408.
[21] Knowles, A. M.; Lawson, A. J Chem Soc, Perkin Trans 1
1972, 1240.
[22] Cook, D. C.; Lawson, A. J Chem Soc, Perkin Trans 1 1974,
1112.
[23] Lo Vecchio, G.; Grassi, G.; Risitano, F.; Foti, F. Tetrahedron
Lett 1973, 39, 3777.
[24] Clerici, F.; Erba, E.; Mornatti, P.; Trimarco, P. Chem Ber
1989, 122, 295.
[25] Cocivera, M.; Emo, A.; Chen, H. E.; Vaish, S. J Am Chem Soc
1976, 98, 7362.
[26] Villemin, D.; Martin, B.; Garrigues, B. Synth Commun 1993,
23, 2251.
4-(4-(Dimethylamino)benzylidene)-3-(chloromethyl)isoxazol-
5(4H)-one (Table 3, entry 5g).
mp 178–180 °C; IR (KBr)
1734, 1589, 1530, 1429, 1180, 1096, 870 cmꢀ1
;
1H NMR
(400 MHz, DMSO-d6) δ 3.19 (s, 6H, (H3C)2 N-), 4.72 (s, 2H,
Cl-CH2-isoxazol), 6.83 (d, J = 8.2 Hz, 2H, Ar-H), 7.72 (s, 1H,
¼CH), 8.46 (d, J = 8.2 Hz, 2H, Ar-H); 13C NMR (100 MHz,
DMSO-d6) δ 35.2, 39.3, 105.4, 111.5, 121.0, 138.0, 150.8,
154.6, 161.1, 169.4; HRMS (m/z): 265.0717 (M + H).+
N-(4-((3-(Chloromethyl)-5-oxoisoxazol-4(5H)-ylidene)methyl)
phenyl)acetamide (Table 3, entry 5 h).
mp 182–184 °C; IR
(KBr) 3333, 3196, 1735, 1600, 1512, 1105, 1010, 956cmꢀ1; H
NMR (300 MHz, CDCl3) δ 2.26 (s, 3H, H3CCO), 4.56 (s, 2H,
Cl-CH2-isoxazol), 7.45 (d, J = 8.8Hz, 2H, Ar-H), 7.54 (bs, 1H,
NH), 7.72 (s, 1H, ¼CH), 8.45 (d, J = 8.8 Hz, 2H, Ar-H); 13C
NMR (75 MHz, CDCl3) δ 29.7, 35.1, 113.6, 115.2, 125.1, 137.1,
151.4, 160.9, 165.7, 169.0; HRMS (m/z): 279.0536 (M + H).+
4-(4-Methylbenzylidene)-3-(chloromethyl)isoxazol-5(4H)-one
1
(Table 3, entry 5i).
mp 178–180 °C; IR (KBr) 1741, 1593,
1522, 1435, 1188, 1091, 877 cmꢀ1;1H NMR (300 MHz, CDCl3)
δ 2.47 (s, 3H, H3C-Ar), 4.56 (s, 2H, Cl-CH2-isoxazol), 7.35
(d, J = 8.2 Hz, 2H, Ar-H), 7.72 (s, 1H, ¼CH), 8.32
(d, J = 8.2 Hz, 2H, Ar-H); 13C NMR (75 MHz, CDCl3) δ 22.3,
35.1, 118.1, 128.8, 129.9, 134.9, 145.8, 150.4, 161.7, 236.0;
MS (m/z): 236.0493 (M + H)+.
4-Benzylidene-3-(chloromethyl)isoxazol-5(4H)-one (Table 3,
entry 5j). mp 184–186 °C; IR (KBr) 1761, 1601, 1552, 1323,
1170, 1085, 922, cmꢀ1 1H NMR (300 MHz, CDCl3) δ 4.50
;
(s, 2H, Cl-CH2-isoxazol), 7.18–7.28 (m, 3H, Ar-H), 7.32 (s, 1H,
¼CH), 7.70 (m, 2H, Ar-H); 13C NMR (75 MHz, CDCl3) δ 34.6,
125.2, 126.8, 128.9, 129.4, 135.1, 151.6, 166.5, 169.0; HRMS
(m/z): 221.0244 (M + H)+.
4-((E)-3-Phenylallylidene)-3-(chloromethyl)isoxazol-5(4H)-
one (Table 3, entry 5k).
mp 186–188 °C; IR (KBr) 1757,
1599, 1546, 1315, 1176, 1096, 868 cmꢀ1; H NMR (300 MHz,
CDCl3) δ 4.52 (s, 2H, Cl-CH2-isoxazol) 7.40 (d, J = 15.8 Hz,
1H, ¼CH), 7.44 (m, 3H, Ar-H), 7.61 (d, J = 15.8 Hz, 1H,
¼CH), 7.66–7.69 (m, 2H, Ar-H), 8.33 (dd, J = 15.8 and
15.8 Hz, 1H, ¼CH); 13C NMR (75 MHz, CDCl3) δ 34.8,
113.6, 121.8, 128.3, 128,9, 131.6, 134.7, 150.7, 153.3, 159.8,
168.0; HRMS (m/z): 248.0465 (M + H)+.
1
[27] Zhang, Y. Q.; Ma, J. J.; Wang, C.; Li, J. C.; Zhang, D. N.;
Zang, X. H.; Li, J. J. Chin J Org Chem 2008, 28, 141.
[28] Liu, Q.; Zhang, Y. Z. Bull Korean Chem Soc 2011, 32, 3559.
[29] Liu, Q.; Wu, R. T. J Chem Res 2011, 10, 598.
[30] Liu, Q.; Hou, X. Phosphorus Sulfur Silicon Relat Elem 2012,
187, 448.
4-((1H-Indol-3-yl)methylene)-3-(chloromethyl)isoxazol-5(4H)-
one (Table 3, entry 5l). mp 240–242 °C; IR(KBr) 1757, 1599,
;
1546, 1315, 1176, 1096, 868cmꢀ1 1H NMR (300 MHz,
DMSO-d6) δ 5.01 (s, 2H, Cl-CH2-isoxazol), 7.37–7.39 (m, 2H,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet